Cyclo Historical Balance Sheet

CYTHW Stock

USD 0.30 0.01 3.45%

Trend analysis of Cyclo Therapeutics balance sheet accounts such as Short Long Term Debt Total of 1.2 M, Total Current Liabilities of 10.2 M or Total Stockholder Equity of 5.7 M provides information on Cyclo Therapeutics' total assets, liabilities, and equity, which is the actual value of Cyclo Therapeutics to its prevalent stockholders. By breaking down trends over time using Cyclo Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cyclo Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cyclo Therapeutics is a good buy for the upcoming year.

Cyclo Therapeutics Inventory

251,900

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.

About Cyclo Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cyclo Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Cyclo Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cyclo Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cyclo currently owns. An asset can also be divided into two categories, current and non-current.

Cyclo Therapeutics Balance Sheet Chart

At this time, Cyclo Therapeutics' Other Current Assets are fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 107 M in 2025, despite the fact that Net Debt is likely to grow to (7 M).

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Cyclo Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cyclo Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cyclo Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cyclo Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Cyclo Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cyclo Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more information on how to buy Cyclo Stock please use our How to Invest in Cyclo Therapeutics guide.At this time, Cyclo Therapeutics' Other Current Assets are fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 107 M in 2025, despite the fact that Net Debt is likely to grow to (7 M).

	2022	2024	2025 (projected)
Short and Long Term Debt Total	1.0M	1.2M	1.2M
Total Assets	4.2M	15.2M	16.0M

Short Long Term Debt Total Total Assets

Cyclo Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Common Stock Total Equity	Property Plant And Equipment Gross	Other Current Liab
Total Assets		0.26	0.79	0.87	-0.13	-0.93	-0.76	0.85	0.98	-0.27	-0.38	0.98	0.62	0.72	-0.26	-0.17	0.61	0.83	0.79	0.99	0.34	-0.28	-0.41	-0.55	-0.14	0.49
Short Long Term Debt Total	0.26		0.49	-0.04	0.65	0.08	-0.43	0.27	0.08	0.54	0.25	0.08	-0.29	0.62	0.37	-0.14	0.52	0.46	0.54	0.16	0.7	-0.22	-0.38	-0.52	0.64	-0.51
Total Current Liabilities	0.79	0.49		0.39	-0.12	-0.6	-0.93	0.96	0.72	-0.3	-0.47	0.72	0.21	0.97	-0.13	-0.19	0.79	0.97	1.0	0.79	0.61	-0.22	-0.2	-0.43	-0.15	0.4
Total Stockholder Equity	0.87	-0.04	0.39		-0.14	-0.93	-0.41	0.51	0.9	-0.2	-0.23	0.9	0.78	0.31	-0.29	-0.06	0.29	0.48	0.38	0.86	0.04	-0.24	-0.44	-0.46	-0.13	0.45
Property Plant And Equipment Net	-0.13	0.65	-0.12	-0.14		0.37	0.29	-0.33	-0.27	0.98	0.69	-0.27	-0.35	-0.04	0.0	0.11	-0.26	-0.23	-0.08	-0.27	0.12	-0.13	-0.1	-0.12	0.99	-0.79
Net Debt	-0.93	0.08	-0.6	-0.93	0.37		0.64	-0.74	-0.98	0.47	0.48	-0.98	-0.74	-0.49	0.29	0.16	-0.47	-0.67	-0.58	-0.95	-0.16	0.21	0.38	0.44	0.37	-0.64
Retained Earnings	-0.76	-0.43	-0.93	-0.41	0.29	0.64		-0.92	-0.71	0.44	0.57	-0.71	-0.3	-0.93	-0.12	0.22	-0.92	-0.98	-0.92	-0.79	-0.73	0.25	0.31	0.49	0.29	-0.43
Accounts Payable	0.85	0.27	0.96	0.51	-0.33	-0.74	-0.92		0.82	-0.48	-0.59	0.82	0.39	0.87	-0.18	-0.24	0.76	0.95	0.94	0.87	0.47	-0.24	-0.15	-0.36	-0.35	0.6
Cash	0.98	0.08	0.72	0.9	-0.27	-0.98	-0.71	0.82		-0.39	-0.45	1.0	0.68	0.62	-0.31	-0.17	0.54	0.77	0.71	0.99	0.23	-0.23	-0.39	-0.5	-0.28	0.6
Non Current Assets Total	-0.27	0.54	-0.3	-0.2	0.98	0.47	0.44	-0.48	-0.39		0.8	-0.39	-0.36	-0.22	0.03	0.12	-0.39	-0.4	-0.25	-0.4	-0.01	-0.14	-0.03	-0.01	0.98	-0.81
Non Currrent Assets Other	-0.38	0.25	-0.47	-0.23	0.69	0.48	0.57	-0.59	-0.45	0.8		-0.45	-0.25	-0.41	0.01	0.02	-0.51	-0.54	-0.42	-0.48	-0.28	-0.18	0.05	0.12	0.69	-0.58
Cash And Short Term Investments	0.98	0.08	0.72	0.9	-0.27	-0.98	-0.71	0.82	1.0	-0.39	-0.45		0.68	0.62	-0.31	-0.17	0.54	0.77	0.71	0.99	0.23	-0.23	-0.39	-0.5	-0.28	0.6
Net Receivables	0.62	-0.29	0.21	0.78	-0.35	-0.74	-0.3	0.39	0.68	-0.36	-0.25	0.68		0.16	-0.25	-0.07	0.22	0.32	0.2	0.65	-0.15	-0.26	-0.07	-0.07	-0.32	0.56
Common Stock Shares Outstanding	0.72	0.62	0.97	0.31	-0.04	-0.49	-0.93	0.87	0.62	-0.22	-0.41	0.62	0.16		0.0	-0.19	0.84	0.96	0.97	0.71	0.7	-0.18	-0.29	-0.52	-0.07	0.26
Non Current Liabilities Total	-0.26	0.37	-0.13	-0.29	0.0	0.29	-0.12	-0.18	-0.31	0.03	0.01	-0.31	-0.25	0.0		-0.18	0.46	0.02	-0.12	-0.25	0.48	-0.05	-0.33	-0.25	0.04	-0.36
Inventory	-0.17	-0.14	-0.19	-0.06	0.11	0.16	0.22	-0.24	-0.17	0.12	0.02	-0.17	-0.07	-0.19	-0.18		-0.26	-0.21	-0.24	-0.18	0.03	-0.43	0.49	0.49	0.12	0.06
Other Current Assets	0.61	0.52	0.79	0.29	-0.26	-0.47	-0.92	0.76	0.54	-0.39	-0.51	0.54	0.22	0.84	0.46	-0.26		0.89	0.78	0.63	0.79	-0.19	-0.41	-0.54	-0.25	0.26
Other Stockholder Equity	0.83	0.46	0.97	0.48	-0.23	-0.67	-0.98	0.95	0.77	-0.4	-0.54	0.77	0.32	0.96	0.02	-0.21	0.89		0.96	0.84	0.66	-0.24	-0.32	-0.52	-0.25	0.44
Total Liab	0.79	0.54	1.0	0.38	-0.08	-0.58	-0.92	0.94	0.71	-0.25	-0.42	0.71	0.2	0.97	-0.12	-0.24	0.78	0.96		0.78	0.6	-0.23	-0.22	-0.45	-0.11	0.36
Total Current Assets	0.99	0.16	0.79	0.86	-0.27	-0.95	-0.79	0.87	0.99	-0.4	-0.48	0.99	0.65	0.71	-0.25	-0.18	0.63	0.84	0.78		0.33	-0.24	-0.39	-0.52	-0.28	0.58
Short Term Debt	0.34	0.7	0.61	0.04	0.12	-0.16	-0.73	0.47	0.23	-0.01	-0.28	0.23	-0.15	0.7	0.48	0.03	0.79	0.66	0.6	0.33		-0.19	-0.33	-0.46	0.15	-0.18
Intangible Assets	-0.28	-0.22	-0.22	-0.24	-0.13	0.21	0.25	-0.24	-0.23	-0.14	-0.18	-0.23	-0.26	-0.18	-0.05	-0.43	-0.19	-0.24	-0.23	-0.24	-0.19		-0.32	-0.26	-0.16	-0.3
Common Stock	-0.41	-0.38	-0.2	-0.44	-0.1	0.38	0.31	-0.15	-0.39	-0.03	0.05	-0.39	-0.07	-0.29	-0.33	0.49	-0.41	-0.32	-0.22	-0.39	-0.33	-0.32		0.96	-0.11	0.23
Common Stock Total Equity	-0.55	-0.52	-0.43	-0.46	-0.12	0.44	0.49	-0.36	-0.5	-0.01	0.12	-0.5	-0.07	-0.52	-0.25	0.49	-0.54	-0.52	-0.45	-0.52	-0.46	-0.26	0.96		-0.11	0.16
Property Plant And Equipment Gross	-0.14	0.64	-0.15	-0.13	0.99	0.37	0.29	-0.35	-0.28	0.98	0.69	-0.28	-0.32	-0.07	0.04	0.12	-0.25	-0.25	-0.11	-0.28	0.15	-0.16	-0.11	-0.11		-0.8
Other Current Liab	0.49	-0.51	0.4	0.45	-0.79	-0.64	-0.43	0.6	0.6	-0.81	-0.58	0.6	0.56	0.26	-0.36	0.06	0.26	0.44	0.36	0.58	-0.18	-0.3	0.23	0.16	-0.8

Click cells to compare fundamentals

Cyclo Therapeutics Account Relationship Matchups

Cyclo Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	14.2M	19.5M	4.2M	13.2M	15.2M	16.0M
Total Current Liabilities	3.7M	3.8M	3.5M	8.5M	9.7M	10.2M
Total Stockholder Equity	10.5M	15.7M	734.5K	4.8M	5.5M	5.7M
Property Plant And Equipment Net	87.9K	77.2K	56.7K	929.3K	1.1M	708.5K
Net Debt	(12.7M)	(16.4M)	(1.5M)	(8.2M)	(7.4M)	(7.0M)
Retained Earnings	(34.1M)	(48.3M)	(63.8M)	(83.9M)	(75.5M)	(71.7M)
Accounts Payable	3.5M	3.7M	2.2M	4.9M	5.6M	5.9M
Cash	12.8M	16.6M	1.5M	9.2M	10.6M	11.2M
Non Current Assets Total	137.7K	84.5K	56.7K	929.3K	836.4K	696.5K
Non Currrent Assets Other	49.8K	7.3K	(56.7K)	38.3K	34.5K	32.8K
Cash And Short Term Investments	12.8M	16.6M	1.5M	9.2M	10.6M	11.2M
Net Receivables	111.8K	539.1K	55.0K	122.4K	140.7K	106.4K
Common Stock Shares Outstanding	1.6M	6.4M	8.4M	16.3M	18.8M	19.7M
Liabilities And Stockholders Equity	14.2M	19.5M	4.2M	13.2M	15.2M	16.0M
Non Current Liabilities Total	62.9K	18.0K	3.5M	22.5K	25.9K	24.6K
Inventory	237.9K	227.4K	254.5K	254.4K	292.5K	251.9K
Other Current Assets	854.4K	2.1M	4.6M	2.7M	3.1M	3.3M
Other Stockholder Equity	44.5M	64.0M	64.5M	88.6M	101.9M	107.0M
Total Liab	3.7M	3.8M	3.5M	8.5M	9.8M	10.3M
Total Current Assets	14.1M	19.4M	4.2M	12.3M	14.2M	14.9M
Common Stock	477.0	841.0	849.0	2.9K	3.3K	3.6K
Common Stock Total Equity	9.1K	12.2K	477.0	849.0	976.35	927.53
Property Plant And Equipment Gross	87.9K	159.3K	158.2K	1.1M	945.1K	533.5K
Other Current Liab	3.5M	3.7M	1.2M	1.6M	2.6M	2.7M
Capital Surpluse	18.7M	26.0M	44.5M	64.5M	74.2M	77.9M
Property Plant Equipment	18.6K	64.6K	87.9K	55.2K	63.5K	51.7K
Net Invested Capital	10.6M	15.8M	734.5K	4.8M	5.5M	5.5M
Net Working Capital	10.4M	15.6M	677.9K	3.9M	4.4M	5.2M
Capital Stock	477.0	841.0	849.0	2.9K	2.6K	3.5K
Capital Lease Obligations	35.9K	19.2K	0.0	1.0M	1.2M	1.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Cyclo Stock Analysis

When running Cyclo Therapeutics' price analysis, check to measure Cyclo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo Therapeutics is operating at the current time. Most of Cyclo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cyclo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo Therapeutics' price. Additionally, you may evaluate how the addition of Cyclo Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cyclo Historical Balance Sheet

Cyclo Therapeutics Inventory

251,900

About Cyclo Balance Sheet Analysis

Cyclo Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Cyclo Therapeutics balance sheet Correlations

Cyclo Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cyclo Therapeutics balance sheet Accounts

Also Currently Popular

Additional Tools for Cyclo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments

Other Stockholder Equity	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Total Current Assets	- 0.95	Net Debt
Common Stock Shares Outstanding	- 0.93	Retained Earnings
Net Debt	- 0.93	Total Stockholder Equity